EPA funds $281,000 to Arkansas to reduce lead in children's drinking water
LITTLE ROCK, Ark. – The Environmental Protection Agency is investing in Arkansas drinking water to benefit children.
The $281,000 in funding is to reduce lead in drinking water at schools and childcare facilities. Officials said the funding is in addition to the $200 million it has put into reducing lead in drinking water since 2018.
EPA announces rollback for some Biden-era limits on 'forever chemicals' in drinking water
In addition to this grant program, EPA's Training, Testing, and Taking Action (3T) program provides information and recommendations to help states and local authorities build voluntary programs to reduce lead in drinking water. Since 2019, this 3T program has helped over 20,000 child care facilities and nearly 13,000 schools have their water tested for lead with over 1,300 child care facilities and 2,500 schools completing remediation work.
'Lead is a neurotoxin that can negatively impact American children,' said EPA Administrator Lee Zeldin. 'With $26 million in funding this year, more schools will be able to identify sources of lead in their water and take action so that our nation's children can focus on learning, playing, and developing skills that will maximize their potential and make our nation stronger.'
Trump EPA moves to repeal climate rules that limit greenhouse gas emissions from US power plants
The Water Infrastructure Improvements for the Nation Act established the Lead Testing in School and Child Care Program Drinking Water grant in 2016 to award funding to states, territories, and tribes to assist local and tribal educational agencies in voluntary testing for lead contamination in drinking water at schools and child care facilities.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
33 minutes ago
- CNET
The Aging Brain: 6 Things You Should Be Doing to Slow Cognitive Decline
When it comes to healthy aging, we tend to focus a lot on body health by exercising and eating well. One thing you might not be thinking about is brain health. But you should be. Your brain runs the rest of your body, and as we age, it changes, too. Cognition declines over time due to several factors, including age-related structure changes, brain injuries or excess stress hormones. According to the Centers for Disease Control and Prevention, one in nine American adults over 65 report cognitive decline. "The parts of our brain that help with learning information and remembering can become smaller, and the brain can weigh less as we age," said Colleen Marshall, chief clinical officer for Two Chairs. Aging doesn't happen at the same rate for everyone, but we all experience it in one way or another. Focusing on brain fitness now may help you slow the change and ensure your brain stays sharp through the years. How to start nourishing your brain for healthy aging 1) Solve puzzles We'll start with the easiest strategy to integrate into your daily life: puzzles. Solving puzzles can benefit the brain in several ways, from improving memory to boosting problem-solving skills. "They may slow the rate of cognitive decline and how quickly the brain decreases in size as we age," Marshall said. A study published in the journal Neurology reported that playing games like checkers or completing jigsaw puzzles can delay the onset of Alzheimer's by about five years. Different research supports the idea that solving crossword puzzles or journaling can lower the risk of dementia. Experts suggest that puzzles help curb cognitive decline because they expand the brain's cognitive reserve, or the ability to solve and cope with problems. Activities to try include putting together jigsaw puzzles or solving other types of puzzles, such as Sudoku, crosswords, memory games and math problems. 2) Learn a new skill Like stimulating the brain by playing games or solving puzzles, learning a new skill has short-term and long-term advantages. By learning a new skill, you're strategically activating several parts of your brain simultaneously. You're also promoting neuroplasticity by creating new pathways and strengthening those connections as you continue honing the skill. It could be learning a new language, painting or trying out a new sport. Just make sure it's challenging or complex, and continue to practice for the best brain results.3) Prioritize sleep Sleep is one of the most important things you can do for your body. While I'm not saying there's a right or wrong way to sleep, research suggests that how much sleep you get and the quality of your sleep influence your risk for dementia. According to a study published in the Journal of Neuroscience, a single night of sleep deprivation can age your brain. A lot goes on in the brain while we sleep, including clearing out toxins and creating new neural pathways. If you don't get enough sleep, your brain doesn't have time to carry out these functions and cognition suffers. Establishing a bedtime routine can have a big impact on your sleep quality. From reading a book to practicing yoga before bed, integrating relaxation into your night can help boost your sleep. 4) Focus on your nutrition What you eat also will influence the rate of cognitive decline you experience as you age. Studies have found that people who follow the Mediterranean and MIND (Mediterranean Dash Intervention for Neurodegenerative Delay) diets tend to have fewer cognitive impairments and dementias compared to those following other diets. More research is needed to conclude why this is true. However, it might have something to do with the way those diets prioritize foods that protect the brain with anti-inflammatory and antioxidant properties. Read more: Master the Mediterranean Diet With the Help of These Tips and Recipes No matter if you choose to follow a strict diet or just improve your current meal rotation, you'll want to focus on improving your blood sugar and dropping high levels of LDL cholesterol to reduce your risk of dementia. Foods to incorporate into your diet for better brain health: Leafy greens like spinach, kale and lettuce Salmon Dark berries Nuts Greek yogurt Dark chocolate Green tea Vegetables like broccoli and carrots 5) Exercise Studies have found that following an active lifestyle is associated with lower cognitive decline over time. Your heart rate increases when you exercise, which increases blood flow to the brain. This can help spark new development of nerve cells, a process called neurogenesis. Exercise also promotes increased connections between cells, making the brain more adaptive. Generally, any exercise that's good for the body will also help the mind. It doesn't have to be lifting weights; walking, swimming and dancing also achieve the same results. Read more: How Exercise Helps Boost Your Memory-Brain Health as You Age6) Make connections with others Marshall pointed out that prioritizing high-quality relationships with others can benefit the brain. According to a meta-analysis of longitudinal cohort studies, limited or poor relationships were associated with cognitive decline. Prioritizing social contact is an essential part of aging well. Whether spending time with your family or putting yourself out there at your local community center, staying connected is an integral part of aging gracefully. Too long; didn't read? Our brains change as we age; there is no way around it. However, integrating any of these easy habits into your routine can help nourish and safeguard your brain for the future. There are also a few things you should avoid to keep your brain in top shape. Heavy cigarette smoking has been associated with cognitive decline in middle age. Marshall added that heavy drinking, poor diet and unmanaged high blood pressure can also negatively impact the brain as we age. Don't worry; there's still time to turn it around. Even if you smoke now, quitting has the potential to return your risk of cognitive decline to a level that's comparable to those who never smoked.
Yahoo
an hour ago
- Yahoo
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds
We recently published a list of . In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other best-performing stocks of Friday. Bausch Health extended its winning streak to a sixth consecutive day on Friday, ending 8.53 percent higher at $5.98 apiece after one of its directors acquired $15 million worth of shares in the company. In a regulatory filing on Thursday, Bausch Health Companies Inc. (NYSE:BHC) said that its director, John Paulson, acquired nearly 2.79 million new shares through his company, Paulson Capital Inc., at a price of $5.05 to $5.47 apiece. A series of pharmaceutical and medical products in a warehouse, displaying the range of products available. No reason was divulged regarding the transaction, but investors may have taken the acquisition as a cue to bargain-hunt on its shares. Paulson's acquisition followed the listed firm's regulatory filing earlier this week that one of its direct subsidiaries and two indirect subsidiaries are planning to raise more than $3 billion in fresh funds through the issuance of a loan facility and revolving credit facility. On Tuesday, the listed firm's direct arm, Bausch + Lomb Corporation, launched a 600-million euro ($693 million) senior notes offering on Tuesday. This was on top of another $3 billion being raised by two indirect subsidiaries through a term B loan facility amounting to $2.2 billion and a revolving credit facility worth $800 million. Bausch Health Companies Inc. (NYSE:BHC) said funds from the fundraising program will be used for the repayment of its direct subsidiary's existing revolving credit facility, refinancing of term loans due 2027, and paying other fees and expenses, as well as general corporate purposes. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs
Americans would likely pay more for necessary everyday prescription drugs, such as insulin, painkillers, chemotherapy, or antibiotics, if President Donald Trump were to enact tariffs on pharmaceuticals, experts warn. In an effort to incentivize drug manufacturers to bring production back to the United States, Trump has proposed tariffing pharmaceuticals made overseas – which account for an overwhelming majority of everyday medicine used in the U.S. 'We're going to be doing that,' Trump said of pharmaceutical tariffs in April. 'That's going to be like we have on cars. You know we have a 25 percent tariff on cars, we have a 25 percent tariff on steel and aluminum, and that's what the [pharmaceutical] category fits right now.' 'The higher the tariff, the faster they come,' Trump said. But experts say that's not necessarily true and there would be tangible consequences to such action, from higher brand-name drug prices to generic drug shortages. 'If tariffs were applied to prescription drugs, one of the most immediate consequences could be price increases — on prices that we already pay way in excess of other countries,' Dr. Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, said. The U.S. imports a majority of its branded prescription drugs – or medications that are patented with a brand name such as Viagra, Wegovy, or Zoloft – from high-income countries. Dr. Jeromie Ballreich, an associated research professor at Johns Hopkins Bloomberg School of Public Health, said much of the manufacturing comes from Ireland, Germany, and Switzerland because they have favorable tax policies for companies. As a result, adding a tariff would only make it more expensive for pharmacies and insurance companies to keep them in supply. 'We would expect pharma to pass the costs onto the insurers and we would expect insurers to pass the cost onto the individual patients,' Ballreich said. 'So, if there is a 50 percent tariff on your insulin product because it's coming from Ireland, patients in Mississippi who get insulin – they will either be faced with a higher cost when they go up to the pharmacy to fill their insulin or they're going to face a higher indirect cost because the premiums of the insurance plan are going to go up,' he said. Ballreich said a tariff on countries that produce high quantities of branded drugs would put 'pressure' on public insurers like Medicare or Medicaid and private insurers. However, branded drugs only account for roughly 10 to 15 percent of prescriptions. A majority of Americans, up to 90 percent, use generic drugs, often manufactured in India and China, because they're cheaper. Making branded drugs less accessible through tariffs would only increase reliance on generic drugs, which could exacerbate shortages that already impact millions of Americans. '[Shortages] can have very significant implications in day-to-day clinical practice,' Socal said. 'For example, if you are administering chemotherapy for an oncology patient, that may have significant consequences even for the prognosis of that case moving forward.' In 2024, the U.S. experienced a shortage of more than 300 drugs – 70 percent of which were generic prescriptions. Socal said that when patients are not able to access a more affordable version of their prescription, it means they may put their health at risk by skipping a dosage, taking a lower dosage, or not filling their prescription at all. Otherwise, they're forced to turn to the more expensive branded version. 'Those more expensive drugs are not always the best,' Socal said. 'Very frequently, and we saw this with chemotherapy shortages, the available drugs are second-line drugs.' The president has indicated that any negative impact from tariffs may be temporary and worth it to bring manufacturing and jobs back. 'We're doing it because we want to make our own drugs,' Trump said. But Ballreich and Socal are more skeptical. 'Tariffs are a very blunt instrument to incentivize domestic U.S. manufacturing of the branded drugs we use,' Ballreich said. Given pharmaceutical companies have moved outside of the U.S. for tax purposes, Ballreich says tax policy may be a better way to incentivize them, especially since many of those drugs are more difficult to manufacture. 'It's not just a very simple chemical plant; these tend to be very complex,' he said. Socal suggested a better strategy would be to understand where drugs are being manufactured and which ones would make more sense to bring to the U.S. — since even those manufactured locally often rely on certain imported ingredients and materials. 'Having tariffs on pharmaceutical products coming from abroad can actually also hurt our domestic manufacturers,' he says. While the president has not officially implemented any tariff policy on pharmaceuticals yet, he said, in April, that the plan would take effect in the 'not too distant future.'
